Growth Metrics

Thermo Fisher Scientific (TMO) Current Assets (2016 - 2026)

Thermo Fisher Scientific filings provide 18 years of Current Assets readings, the most recent being $22.3 billion for Q1 2026.

  • On a quarterly basis, Current Assets fell 4.54% to $22.3 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $22.3 billion, a 4.54% decrease, with the full-year FY2025 number at $28.7 billion, up 29.68% from a year prior.
  • Current Assets hit $22.3 billion in Q1 2026 for Thermo Fisher Scientific, down from $28.7 billion in the prior quarter.
  • In the past five years, Current Assets ranged from a high of $28.7 billion in Q4 2025 to a low of $18.1 billion in Q3 2022.
  • Median Current Assets over the past 5 years was $23.1 billion (2023), compared with a mean of $22.7 billion.
  • Biggest five-year swings in Current Assets: fell 21.94% in 2022 and later grew 29.68% in 2025.
  • Thermo Fisher Scientific's Current Assets stood at $25.2 billion in 2022, then dropped by 2.54% to $24.6 billion in 2023, then decreased by 9.97% to $22.1 billion in 2024, then grew by 29.68% to $28.7 billion in 2025, then fell by 22.26% to $22.3 billion in 2026.
  • The last three reported values for Current Assets were $22.3 billion (Q1 2026), $28.7 billion (Q4 2025), and $22.3 billion (Q3 2025) per Business Quant data.